NeuroSense Therapeutics’ Prime, a drug developed in Tel Aviv, demonstrates a 30% slowdown in disease progression in phase 2 trials | Read More in ynet – Culture
Israeli ALS drug shows promise in slowing disease progression
Recent Posts
YnetNews
U.S. will abandon Ukraine peace push if no progress ‘within a matter of days,’ Rubio saysApril 18, 2025
‘Seven hours in hell’: Three women recall horrors of Nova Festival massacreApril 18, 2025
New details on fatal Italy cable-car crash emerge: ‘Suddenly they heard breathing’April 18, 2025
Former hostage on Rom Braslavski’s video: ‘His eyes are not the same’April 18, 2025
Arutz Sheva
Suspects arrested for ordering grenade sent to governorApril 18, 2025
Hostages’ families: Deal must bring everyone home, in one stageApril 18, 2025
Iranian Crown Prince: ‘Nuclear talks will not bring peace to the Middle East’April 18, 2025
Little known facts about PassoverApril 18, 2025
Israel21c
Muscle-loss concerns lead to new drug discovery platformApril 17, 2025
15 beautiful artworks not to miss in Israel’s Christian sitesApril 17, 2025
Diversity becomes the key as Hebrew University celebrates 100 April 16, 2025
‘Inglourious Basterds’ star joins ‘Fauda’ Season 5April 16, 2025
A simple lifesaver for hemorrhagic shock or cardiac arrestApril 15, 2025
JTA
- U.S. will abandon Ukraine peace push if no progress ‘within a matter of days,’ Rubio saysApril 18, 2025
- 5 injured in an accident between two vehicles in northApril 18, 2025
- Defense Minister: We will do everything necessary to prevent Iran from acquiring nuclear weaponsApril 18, 2025
Josh Shapiro recounts arson terror but does not back Schumer’s call for federal hate crime investigationApril 18, 2025- Prime Minister Netanyahu refused to allow Jordanian helicopters to fly Mahmoud Abbas to DamascusApril 18, 2025